Related Experiment Videos
Cortisol nonsuppression in depression: relationship to clinical variables
1Clinical Neuroscience Branch, National Institute of Mental Health, Bethesda, MD 20892.
Journal of Affective Disorders
|May 1, 1988
Summary
The dexamethasone suppression test revealed cortisol nonsuppression in nearly half of depressed patients, unlike normal controls. This finding suggests a potential biomarker for depression, linked to age, weight loss, and personality traits.
Area of Science:
- Neuroendocrinology
- Psychiatry
- Clinical Psychology
Background:
- The hypothalamic-pituitary-adrenal (HPA) axis is frequently dysregulated in major depressive disorder.
- The dexamethasone suppression test (DST) is a widely used neuroendocrine challenge to assess HPA axis function.
Purpose of the Study:
- To investigate cortisol nonsuppression rates in a cohort of depressed patients compared to healthy controls.
- To explore clinical and psychological correlates of cortisol suppression status in depression.
Main Methods:
- Administered the dexamethasone suppression test to 63 patients diagnosed with depression and 43 healthy controls.
- Measured postdexamethasone plasma cortisol levels.
- Assessed patient age, reported weight loss, depression severity, recent life events, and hostility scores.
Main Results:
- Cortisol nonsuppression was observed in 47.6% of depressed patients versus 4.6% of controls (p < 0.001).
- In depressed patients, age and weight loss significantly correlated with postdexamethasone cortisol levels.
- Cortisol suppressors reported more pre-depression life events and higher hostility scores than nonsuppressors.
Conclusions:
- Cortisol nonsuppression is significantly more prevalent in depressed individuals, suggesting HPA axis dysregulation.
- Clinical factors like age and weight loss, alongside psychological traits such as hostility and life event exposure, are associated with DST results in depression.